Scoreflex NC Scoring PTCA Catheter 617-104-1URecalls & reported problems
OrbusNeich Medical (ShenZhen) Co., Ltd. · Class 3
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 06934955936258), received between May 15, 2024 and May 15, 2024 — classified as 1 malfunction.
The most frequently reported specific device problem is “Material Split, Cut or Torn” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Material Split, Cut or Torn1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 15, 2024Material Split, Cut or Torn; Material Split, Cut or Torn
MULTIPLE NON-CSI/NON-ABBOTT BALLOONS WERE ATTEMPTED TO BE USED IN A SUPER TIGHT PROXIMAL LEFT ANTERIOR DESCENDING ARTERY (LAD) LESION, HOWEVER, THE BALLOONS RUPTURED. A SCOREFLEX BALLOON WAS ATTEMPTED TO BE USED IN THE LAD WHEN IT BACKED THE GUIDE UP AND THE WIRE LOOP WAS BEHIND THE SHORT RAPID EXCHANGE CATHETER. THE PHYSICIAN PROCEEDED TO PULL THE BALLOON WITH THE LOOP AND THE BALLOON CAME OFF OF THE WIRE. THE ENTIRE WIRE AND TELEFLEX GUIDELINER WERE PULLED OUT OF THE PATIENT. IT APPEARED THAT THE RAPID EXCHANGE CATHETER MAY HAVE SPLIT, BUT THIS WAS UNABLE TO BE CONFIRMED. THE GUIDELINER WAS FLUSHED AND THE PHYSICIAN RE-WIRED WITH A NEW WIRE TO COMPLETE THE PROCEDURE. BACKGROUND: A SUPER TIGHT PROXIMAL LEFT ANTERIOR DESCENDING ARTERY (LAD) LESION. IT WAS REPORTED AS NO PATIENT COMPLICATIONS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19318156 ↗
Other Catheter, Percutaneous Transluminal Coronary Angioplasty (Ptca), Cutting/Scoring devices
- Wolverine Coronary Cutting Balloon H74939401103000Boston Scientific Corporation · Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring1 death36 reports
- Wolverine Coronary Cutting Balloon H74939401103500Boston Scientific Corporation · Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring21 reports
- Wolverine Coronary Cutting Balloon H74939401153000Boston Scientific Corporation · Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring19 reports
- Wolverine Coronary Cutting Balloon H74939401153500Boston Scientific Corporation · Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring19 reports
- Wolverine Coronary Cutting Balloon H74939401104000Boston Scientific Corporation · Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring19 reports
- Wolverine Coronary Cutting Balloon H74939401102500Boston Scientific Corporation · Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring16 reports
- Wolverine Coronary Cutting Balloon H74939401154000Boston Scientific Corporation · Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring15 reports
- AngioSculpt PTCA RX Scoring Balloon Catheter 2200-3010Spectranetics Corporation · Catheter, Percutaneous Transluminal Coronary Angioplasty (Ptca), Cutting/Scoring2 deaths14 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page